Hythiam® - Press Releases /

Press Releases

Date	Title
03/01/10	Hythiam to Present at the Roth 22nd Annual OC Growth Stock Conference
02/25/10	Hythiam Receives NASDAQ Notification
02/10/10	Hythiam Announces Peer-Reviewed Publication of Randomized, Double-Blind, Placebo-Controlled Study
01/13/10	Hythiam Announces Publication on Predictive Modeling for Substance Dependent Populations in Perspectives in Health Information Management
12/01/09	Hythiam Granted Continued Listing on NASDAQ
11/09/09	Hythiam Announces Third Quarter Results
09/28/09	Hythiam Announces First Peer-Reviewed Publication of Statistically Significant Results from Randomized, Double-Blind, Placebo-Controlled Study
09/23/09	Hythiam Announces the Closing of $7 Million Registered Direct Offering
09/18/09	Hythiam Receives NASDAQ Notification Regarding Bid Price; Grace Period Granted Through March 15, 2010
09/17/09	Hythiam Raises Approximately $7 Million in Registered Direct Offering
09/17/09	Hythiam Enters into Agreement with Ford Motor Company for Catasys Integrated Substance Dependence Solution
09/08/09	Hythiam Presentation at Rodman and Renshaw Annual Global Investment Conference to Be Simultaneously Webcast
09/03/09	Hythiam Announces Presentation at the Rodman and Renshaw Annual Global Investment Conference
08/28/09	Hythiam Receives NASDAQ Staff Determination
08/10/09	Hythiam Announces Second Quarter Results
07/20/09	Hythiam Receives Extension From Nasdaq to Regain Compliance With Minimum Stockholders' Equity Requirement
05/19/09	Hythiam Receives Notice from Nasdaq Regarding Noncompliance with Minimum Stockholders' Equity Requirement
05/11/09	Hythiam Announces First Quarter Results
04/01/09	Catasys(TM) Presents with Ford Motor Company at the 4(th) Annual Behavioral Risk in the Workplace Conference
03/31/09	Hythiam Announces Fourth Quarter and 2008 Year-End Results
03/31/09	CORRECTING and REPLACING Hythiam Announces Results of Two Double-Blind, Placebo-Controlled Studies on Impact of PROMETA® Treatment Program for Alcohol Dependence
03/31/09	CORRECTING and REPLACING Hythiam Announces Results of Two Double-Blind, Placebo-Controlled Studies on Impact of PROMETA((R)) Treatment Program for Alcohol Dependence
03/30/09	Hythiam to Announce Fourth Quarter and Fiscal 2008 Year-End Results on Tuesday, March 31(st)
03/27/09	Kelly Ellston Joins Hythiam as Senior Vice President of Catasys(TM) Operations
03/26/09	Hythiam Announces Results of Two Double-Blind, Placebo-Controlled Studies on Impact of PROMETA(R) Treatment Program for Alcohol Dependence